Phase I dose-finding study of the gamma secretase inhibitor PF-03084014 (PF-4014) in combination with docetaxel in patients (pts) with advanced triple-negative breast cancer (TNBC) / G. Curigliano, P.G.A.. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 33:15, suppl(2015 May), pp. 1068-1068. (Annual Meeting of the American Society of Clinical Oncology. ASCO Annual Meeting. Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer : May 29-June 02 Chicago (Illinois) 2015) [10.1200/JCO.2015.33.15_SUPPL.1068].
Phase I dose-finding study of the gamma secretase inhibitor PF-03084014 (PF-4014) in combination with docetaxel in patients (pts) with advanced triple-negative breast cancer (TNBC)
G. CuriglianoPrimo
;
2015
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
